Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans.
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Plasma leptin levels correlate strongly with increased total adipose tissue, a known risk factor for type 2 diabetes, yet the role of leptin in the etiology of diabetes remains unclear. We sought to determine whether leptin is a risk factor for development of diabetes in Japanese Americans. RESEARCH DESIGN AND METHODS: We compared baseline leptin levels in 370 nondiabetic Japanese Americans who remained nondiabetic for 5-6 years of follow-up with those of 40 nondiabetic Japanese Americans who developed diabetes during follow-up. All participants had computed tomography measurements of baseline subcutaneous chest, abdomen, thigh, and intra-abdominal fat, with total fat defined as the sum of all these measurements. RESULTS: The mean age was 51.7 +/- 11.7 years for men and 51.9 +/- 12.0 years for women. The 23 men who developed diabetes had significantly higher leptin levels than the 212 men who remained nondiabetic (P < 0.01). Among men, baseline leptin levels predicted diabetes risk independent of baseline total fat, insulin, insulin resistance, glucose, or age in separate multiple logistic regression models (relative risk adjusted for baseline total fat = 1.80 per SD increase [2.7 ng/ml], 95% CI 1.02-3.17). This association was particularly strong among men in the top decile for intra-abdominal fat. In contrast, the 17 women who developed diabetes had leptin levels similar to those of the 158 women who remained nondiabetic (P = 0.31). CONCLUSIONS: Among Japanese Americans, increased baseline leptin levels are associated with increased risk of developing diabetes in men but not in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Endothelial dysfunction in diabetes
De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703393 · Cited by 1,165
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Diabetic Retinopathy and Diabetic Macular Edema
Ciulla, T. A., Amador, A. G., & Zinman, B. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2653 · Cited by 836
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 825
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Leptin and Cardiovascular Disease: Response to Therapeutic Interventions
Koh, K. K., Park, S. M., & Quon, M. J. (2008) · Circulation · doi:10.1161/circulationaha.107.741645 · Cited by 479
The role of adipokines in health and disease
Clemente-Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., Martínez-Guardado, I., Navarro-Jiménez, E., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2023) · Biomedicines · doi:10.3390/biomedicines11051290 · Cited by 463
High and low hemoglobin glycation phenotypes in type 1 diabetes
Hempe, J. M., Gomez, R., McCarter, R. J., & Chalew, S. A. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00227-6 · Cited by 322
Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy
Ramirez, M. A., & Borja, N. L. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.646 · Cited by 303
Fetuin-A and Incident Diabetes Mellitus in Older Persons
Ix, J. H. (2008) · JAMA · doi:10.1001/jama.300.2.182 · Cited by 267
Adipose tissue: an endocrine organ playing a role in metabolic regulation
Booth, A., Magnuson, A., Fouts, J., & Foster, M. T. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0073 · Cited by 208
Increased plasma leptin in gestational diabetes
Kautzky-Willer, A., Pacini, G., Tura, A., Bieglmayer, C., Schneider, B., Ludvik, B., Prager, R., & Waldhäusl, W. (2001) · Diabetologia · doi:10.1007/s001250051595 · Cited by 194
Ocular Associations of Diabetes Other Than Diabetic Retinopathy
Jeganathan, V. S. E., Wang, J. J., & Wong, T. Y. (2008) · Diabetes Care · doi:10.2337/dc08-0342 · Cited by 185
The Potential Role of PKC β in Diabetic Retinopathy and Macular Edema
Aiello, L. P. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00391-0 · Cited by 165
Presence and Risk Factors for Glaucoma in Patients with Diabetes
Song, B. J., Aiello, L. P., & Pasquale, L. R. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0815-6 · Cited by 163
Kautzky-Willer, A., Krssak, M., Winzer, C., Pacini, G., Tura, A., Farhan, S., Wagner, O., Brabant, G., Horn, R., Stingl, H., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.244 · Cited by 150
“The close association between IMCL and elevated plasma total leptin concentrations correlating with insulin secretion, insulin resistance, and BFM in pGDM could point at increased weight retention postpartum (48,49) and risk for later type 2 diabetes (50,51).”
Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
Sattar, N., Wannamethee, S. G., & Forouhi, N. G. (2008) · Diabetologia · doi:10.1007/s00125-008-0954-7 · Cited by 143
Sleep duration and circulating adipokine levels
Hayes, A. L., Xu, F., Babineau, D., & Patel, S. R. (2011) · Sleep · doi:10.1093/sleep/34.2.147 · Cited by 114
Leptin and Wound Inflammation in Diabetic ob/ob Mice
Goren, I., Kämpfer, H., Podda, M., Pfeilschifter, J., & Frank, S. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2821 · Cited by 95
Leptin and other components of the Metabolic Syndrome in Mauritius—a factor analysis
Hodge, A., Boyko, E., de Courten, M., Zimmet, P., Chitson, P., Tuomilehto, J., & Alberti, K. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801522 · Cited by 80
Self-citationEnteric neuropathy in diabetes: Implications for gastrointestinal function
Abdalla, M. M. I. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i22.2852 · Cited by 45
Maple-Brown, L., Ye, C., Hanley, A. J., Connelly, P. W., Sermer, M., Zinman, B., & Retnakaran, R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2290 · Cited by 41
Lilja, M., Rolandsson, O., Norberg, M., & Söderberg, S. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0123 · Cited by 39
Obesity and Exercise: New Insights and Perspectives
James, N. M., & Stanford, K. I. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf017 · Cited by 20
Metadata
- Authors
- McNeely, M. J., Boyko, E. J., Weigle, D. S., Shofer, J. B., Chessler, S. D., Leonnetti, D. L., & Fujimoto, W. Y.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1999-01-01
- Volume
- 22
- Issue
- 1
- Pages
- 65-70
- ISSN
- 0149-5992
- 1935-5548
- OpenAlex
- W2016560465
- Cited by
- 308
- References
- 0
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.